By Dr. Michael Bilof Last month I did a brief overview here of the medical research on the new ‘wonder weight loss drugs’ that are on the market. In case you did not read it or didn’t know there are new ‘wonder drugs’ in our midst, the 2 drugs are Semaglutide (brand name Wegovy/Ozempic) and Tirzepatide (brand name Mounjaro). The take home message from the research literature is that these drugs are effective for a significant number of the patients who take them (at least half in most of the studies) and, more importantly, they are relatively safe. Since we